BRIEF-Dyne Therapeutics Says Co Prices Public Offering At $18.44 Per Share

Reuters12-10 10:45

BRIEF-Dyne <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Says Co Prices Public Offering At $18.44 Per Share

Dec 9 (Reuters) - Dyne Therapeutics Inc DYN.O:

DYNE THERAPEUTICS ANNOUNCES PRICING OF UPSIZED $350.0 MILLION PUBLIC OFFERING OF COMMON STOCK
DYNE THERAPEUTICS INC - PUBLIC OFFERING PRICED AT $18.44 PER SHARE, $350 MILLION EXPECTED PROCEEDS

Source text: ID:nGNX51x8n1

Further company coverage: DYN.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2590371014?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-10 10:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590371014","market":"nz","top_or_hot":-1,"title":"BRIEF-Dyne Therapeutics Says Co Prices Public Offering At $18.44 Per Share","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Dyne <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Says Co Prices Public Offering At $18.44 Per Share</title></head><body><p><span>Dec 9 (Reuters)</span><span> - </span>Dyne Therapeutics Inc <span>DYN.O</span>:</p><ul><li><p>DYNE THERAPEUTICS ANNOUNCES PRICING OF UPSIZED $350.0 MILLION PUBLIC OFFERING OF COMMON STOCK</p></li><li><p>DYNE THERAPEUTICS INC - PUBLIC OFFERING PRICED AT $18.44 PER SHARE, $350 MILLION EXPECTED PROCEEDS</p></li></ul><p>Source text: <span>ID:nGNX51x8n1</span></p><p>Further company coverage: <span>DYN.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Dyne Therapeutics Says Co Prices Public Offering At $18.44 Per Share</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Dyne Therapeutics Says Co Prices Public Offering At $18.44 Per Share\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-10 10:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Dyne <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Says Co Prices Public Offering At $18.44 Per Share</title></head><body><p><span>Dec 9 (Reuters)</span><span> - </span>Dyne Therapeutics Inc <span>DYN.O</span>:</p><ul><li><p>DYNE THERAPEUTICS ANNOUNCES PRICING OF UPSIZED $350.0 MILLION PUBLIC OFFERING OF COMMON STOCK</p></li><li><p>DYNE THERAPEUTICS INC - PUBLIC OFFERING PRICED AT $18.44 PER SHARE, $350 MILLION EXPECTED PROCEEDS</p></li></ul><p>Source text: <span>ID:nGNX51x8n1</span></p><p>Further company coverage: <span>DYN.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DYN","symbol_name":"戴纳基","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nTUA1PMBCR:1","article_id":"2590371014","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590371014","pubTimestamp":1765334741,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Dyne Therapeutics Says Co Prices Public Offering At $18.44 Per ShareDec 9 (Reuters) - Dyne Therapeutics Inc DYN.O:DYNE THERAPEUTICS ANNOUNCES PRICING OF UPSIZED $350.0 MILLION PUBLIC OFFERING OF","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DYN":"戴纳基","BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4505":"高瓴资本持仓","BK4139":"生物科技"},"translate_title":"BRIEF-Dyne Therapeutics表示公司公开发行定价为每股18.44美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DYN":0.9},"content_text":"BRIEF-Dyne Therapeutics Says Co Prices Public Offering At $18.44 Per ShareDec 9 (Reuters) - Dyne Therapeutics Inc DYN.O:DYNE THERAPEUTICS ANNOUNCES PRICING OF UPSIZED $350.0 MILLION PUBLIC OFFERING OF COMMON STOCKDYNE THERAPEUTICS INC - PUBLIC OFFERING PRICED AT $18.44 PER SHARE, $350 MILLION EXPECTED PROCEEDSSource text: ID:nGNX51x8n1Further company coverage: DYN.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2590371014","isCrawlerRequest":true}